Tempus AI, Inc. Class A Common Stock Price, Chart & Factor Exposure
Free Data & Analytics AccessLatest earnings: November 2, 2026 results vs estimates
Tempus AI, Inc. Class A Common Stock Forecast
Tempus AI, Inc. Class A Common Stock short-term momentum is positive (up over 3 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (7 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 88.0% a year, a typical one-standard-deviation range is 68.19–87.49 over a week, 58.07–97.61 over a month and 9.3668–146.31 over a year. (Signals as of 1 Nov 2026.)
Tempus AI, Inc. Class A Common Stock Price Chart
Tempus AI, Inc. Class A Common Stock Factors
YoY −16.0%
YoY +16.5%
YoY −15.2%
YoY −47.4%
YoY −19.1%
YoY +14.8%
YoY +37.9%
YoY −20.5%
YoY −20.4%
YoY +14.0%
YoY +8.8%
YoY +33.3%
YoY +8.8%
Tempus AI, Inc. Class A Common Stock fundamentals: income statement, balance sheet & cash flow
Tempus AI, Inc. Class A Common Stock reported revenue of $1.27bn and net income of -$245.0m in FY2025, the year ended 31 December 2025 — revenue up 83.4% and net income up 65.3% on the prior year. Free cash flow was -$245.4m. These figures are as reported in the filings, not restated: 7 fiscal years and 24 quarters of history, back to December 2019. 57 FINRA short-interest settlements are published alongside them, back to June 2024.
| USD millions | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
| Revenue | 1,271.8 | 693.4 | 531.8 | 320.7 | 257.9 |
| Cost of revenue | 473.9 | 312.3 | 245.6 | 190.5 | 174.2 |
| Gross profit | 797.9 | 381.1 | 286.2 | 130.2 | 83.6 |
| Research & development | 319.0 | 316.8 | 185.5 | 162.3 | 128.4 |
| Selling, general & admin. | — | 755.4 | 296.8 | 233.4 | 199.0 |
| Operating income | -252.9 | -691.1 | -196.1 | -265.4 | -243.7 |
| EBITDA | -118.5 | -610.4 | -133.3 | -236.8 | -219.5 |
| Interest expense | 70.3 | 53.7 | 46.9 | 21.9 | 15.2 |
| Pre-tax income | -296.7 | -705.5 | -213.8 | -289.7 | -259.2 |
| Income tax | -51.7 | 0.3 | 0.3 | 0.1 | 0.6 |
| Net income | -245.0 | -705.8 | -214.1 | -289.8 | -259.2 |
Download Tempus AI, Inc. Class A Common Stock fundamentals
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.TEM.NASDAQ&statement=all&freq=a&format=csv&years=10
Figures in USD, statements as filed and FINRA consolidated short interest. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic. Short interest is the consolidated FINRA figure for the settlement date shown, published seven to eight business days later.
Research on Tempus AI, Inc. Class A Common Stock
Explore MacroFinance macro & markets research and analysis.
Tempus AI, Inc. Class A Common Stock Trading Strategies
58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Tempus AI, Inc. Class A Common Stock; 28 of them are invested now. Strategies currently invested are listed first.
| Strategy | Style | Rebalance | Now in SPY, XLV | CAGR | Sharpe | Max DD |
|---|---|---|---|---|---|---|
| Tactical Permanent Portfolio | Conservative | Monthly | Premium · upgrade to view | |||
| Zakamulin and Giner's Optimal Trend Following | Moderate | Monthly | Premium · upgrade to view | |||
| Movement Capital's Composite Strategy | Moderate | Monthly | Premium · upgrade to view | |||
| Harry Browne's Permanent Portfolio | Conservative | Monthly | 25% | 7.0% | 0.96 | -17.2% |
| Keller and Van Putten's Flexible Asset Allocation | Moderate | Monthly | Premium · upgrade to view | |||
| Ned Davis' Three Way Model | Moderate | Monthly | Premium · upgrade to view | |||
| 60_40 Benchmark | Moderate | Monthly | 60% | 8.2% | 0.93 | -29.5% |
| Dick Stoken's Active Combined Asset (ACA) - Monthly Trading | Moderate | Monthly | Premium · upgrade to view | |||
| PortfolioCharts' Golden Butterfly | Moderate | Monthly | 20% | 7.4% | 0.91 | -18.0% |
| US Cross-Asset Momentum | Moderate | Monthly | Premium · upgrade to view | |||
Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.
From creators
- P4 Demo Momentum by admin
- strategyx by admin
Statistical Distribution of Returns
PlusHow Tempus AI, Inc. Class A Common Stock’s returns are distributed — and how they change in a given market regime.
Regime filters
| Market/Macro | Indicator | Criteria | Value | And (for Between) | Action |
|---|
No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.
| Statistic | All periods | Matching |
|---|
About Tempus AI, Inc. Class A Common Stock (United States)
Tempus AI, Inc. Class A Common Stock is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).
Last updated: November 22, 2026
More on Tempest Minerals Ltd
Frequently asked questions
What is Tempus AI, Inc. Class A Common Stock?
What is the latest Tempus AI, Inc. Class A Common Stock price?
Is Tempus AI, Inc. Class A Common Stock in an uptrend?
How volatile is Tempus AI, Inc. Class A Common Stock?
What factors affect Tempus AI, Inc. Class A Common Stock?
Which trading strategies trade Tempus AI, Inc. Class A Common Stock?
How are Tempus AI, Inc. Class A Common Stock returns analysed?
Where can I download free Tempus AI, Inc. Class A Common Stock historical data?
Free Tempus AI, Inc. Class A Common Stock historical data (last 10 years)
Browse or instantly download the last 10 years of Tempus AI, Inc. Class A Common Stock daily price history. A free account unlocks the full history, an Excel export with factors, and API access.
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.TEM.NASDAQ&format=csv&years=10
| Date | Close |
|---|---|
| 2026-11-20 | 54.04 |
| 2026-11-19 | 59.61 |
| 2026-11-18 | 63.62 |
| 2026-11-17 | 63.43 |
| 2026-11-16 | 64.76 |
| 2026-11-13 | 71.6 |
| 2026-11-12 | 75.89 |
| 2026-11-11 | 79.43 |
| 2026-11-10 | 80.54 |
| 2026-11-09 | 84.44 |
About this stock
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
See how this market's returns behaved when a factor was in a given state, for example when Momentum was strong or bond yields were above 4%, and compare that with all periods.
Reading the chart
- Each bar is a return bucket; its height is the share of periods that landed there.
- All periods: every return in the date range.
- Matching periods: only the periods where all your filters were true. If orange shifts right of the grey, returns were better in that regime.
- Each period's return is the return over the following day, week or month (set by Timeframe), measured from the day the factor was read, so there is no look-ahead.
Adding a filter
- Factor: grouped the same way as the Factors section on this page (Quantitative, Country, Sector, …). Locked factors are listed but greyed out.
- Criteria: greater (>), greater or equal (≥), equal (=), smaller or equal (≤), smaller (<) or between two values.
- Value: depends on the factor.
- Momentum and Trend are signals from −1 to +1, picked as −100 to +100 in steps of 25.
- Mean Reversion is a z-score of price against its 250-day mean, picked in σ from −3 to +3.
- Everything else is a number you type. The line under the box shows the latest reading and its typical range over the last 10 years.
Add several filters to combine conditions; a period must pass every one. Narrow the window with the From/To dates or the 1Y / 5Y / 10Y / MAX buttons; Clear resets filters and dates.
Return statistics
- Unfiltered vs Filtered: all periods vs matching periods.
- Average return, Std dev and Sharpe are annualised (252 days, 52 weeks, 12 months, 6 two-month periods, 4 quarters).
- Maximum drawdown compounds non-overlapping periods; in the Filtered column it assumes you held only while the condition was true.
- Min, 25th percentile, median, 75th percentile and max are per period, not annualised.